Your browser doesn't support javascript.
loading
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.
Facon, Thierry; Dimopoulos, Meletios A; Dispenzieri, Angela; Catalano, John V; Belch, Andrew; Cavo, Michele; Pinto, Antonello; Weisel, Katja; Ludwig, Heinz; Bahlis, Nizar J; Banos, Anne; Tiab, Mourad; Delforge, Michel; Cavenagh, Jamie D; Geraldes, Catarina; Lee, Je-Jung; Chen, Christine; Oriol, Albert; De La Rubia, Javier; White, Darrell; Binder, Daniel; Lu, Jin; Anderson, Kenneth C; Moreau, Philippe; Attal, Michel; Perrot, Aurore; Arnulf, Bertrand; Qiu, Lugui; Roussel, Murielle; Boyle, Eileen; Manier, Salomon; Mohty, Mohamad; Avet-Loiseau, Herve; Leleu, Xavier; Ervin-Haynes, Annette; Chen, Guang; Houck, Vanessa; Benboubker, Lotfi; Hulin, Cyrille.
Afiliação
  • Facon T; Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Dispenzieri A; Mayo Clinic, Rochester, MN.
  • Catalano JV; Frankston Hospital and Monash University, Frankston, Australia.
  • Belch A; Cross Cancer Institute, Edmonton, Canada.
  • Cavo M; Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
  • Pinto A; Department of Hematology and Developmental Therapeutics, Hematology/Oncology and Stem Cells Transplantation Unit, National Cancer Institute, Fondazione "Pascale," Naples, Italy.
  • Weisel K; Department of Hematology, University of Tuebingen, Tuebingen, Germany.
  • Ludwig H; Wilhelminenspital, Center for Oncology, Vienna, Austria.
  • Bahlis NJ; Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Canada.
  • Banos A; Centre Hospitalier de la Côte Basque, Bayonne, France.
  • Tiab M; Department of Hematology, University Hospital, La Roche Sur Yon, France.
  • Delforge M; University Hospital Leuven, Leuven, Belgium.
  • Cavenagh JD; Barts Health National Health Service Trust, London, United Kingdom.
  • Geraldes C; Hospitais da Universidade de Coimbra, Coimbra, Portugal.
  • Lee JJ; Chonnam National University Hwasun Hospital, Jeollanamdo, South Korea.
  • Chen C; Princess Margaret Hospital, Toronto, Canada.
  • Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain.
  • De La Rubia J; Hospital Dr. Peset, Valencia, Spain.
  • White D; Queen Elizabeth II Health Sciences Centre, Halifax, Canada.
  • Binder D; Kantonsspital Winterthur, Winterthur, Switzerland.
  • Lu J; Peking University People's Hospital, Beijing, China.
  • Anderson KC; Dana-Farber Cancer Institute, Boston, MA.
  • Moreau P; Department of Hematology, University of Nantes, Nantes, France.
  • Attal M; Institut Universitaire du Cancer, Toulouse-Oncopole, France.
  • Perrot A; Centre Hospitalier Régional Universitaire de Nancy, Université de Lorraine, Nancy, France.
  • Arnulf B; Hopital Saint Louis, Paris, France.
  • Qiu L; Blood Disease Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China.
  • Roussel M; Centre Hospitalier Universitaire Purpan/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
  • Boyle E; Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
  • Manier S; Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
  • Mohty M; Hôpital Saint-Antoine, Paris, France.
  • Avet-Loiseau H; Unite de Genomique du Myelome, Centre Hospitalier Universitaire Rangueil, Toulouse, France.
  • Leleu X; Hôpital de la Milétrie, Centre Hospitalier Universitaire INSERM, Poitiers, France.
  • Ervin-Haynes A; Celgene Corporation, Summit, NJ.
  • Chen G; Celgene Corporation, Summit, NJ.
  • Houck V; Celgene Corporation, Summit, NJ.
  • Benboubker L; Centre Hospitalier Universitaire Hôpital Bretonneau, Tours Cedex, France; and.
  • Hulin C; Bordeaux Hospital University Center (Centre Hospitalier Universitaire), Bordeaux, France.
Blood ; 131(3): 301-310, 2018 01 18.
Article em En | MEDLINE | ID: mdl-29150421
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França